LEVOKETOCONAZOLE | STRONGBRIDGE | ||
150MG | |||
No | No | ||
2040-Mar-02 | Expired | ||
None | None | ||
None | No | ||
RECORLEV is a cortisol synthesis inhibitor indicated for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome for whom surgery is not an option or has not been curative. |
0 | 0 | 0 |
Total Other Developers | 3 |
---|
Drugs with Suitability | No |
---|
150MG | ** | ** | - | - | - |
NDA Sales Available | Total Generic Sales Available |
---|---|
Yes | 0 |
ANDA No | Generic Co | Manufacturer Name | Operations | Manufacturer Address | Country |
---|
Download GenUS Drug Report
Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023
+91 94997 68112
nimish@researchdelta.com